| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |